KPV injectable peptide vial

KPV is a three-amino-acid anti-inflammatory peptide fragment of alpha-MSH, studied for gut and skin inflammation. It is compounded and not FDA-approved as a finished drug. Ivologist prescribes it as capsules or within the KLOW combination vial after a medical telehealth consultation.

KPV Peptide

A physician-supervised KPV protocol for gut and skin inflammation. KPV is a three-amino-acid fragment of alpha-MSH studied for targeted anti-inflammatory action, available as capsules or within a combination vial. Programs include an online provider consultation, medication, supplies, and ongoing clinician guidance. Eligibility is determined by a licensed healthcare provider.

Choose your cyclesCapsules or Injectable84 capsules per cycle
1 cycleLaunch special
$899$800

12 weeks · 1 × 12-week cycle · $800/cycle

You save $99

Every cycle includes
  • Clinician consultation
  • Peptide medication
  • Free shipping
  • May require labs

One-time payment, not a subscription. Up to 3 cycles per year. A cycle is the program length; your provider decides whether treatment is right for you and sets your dose, schedule and duration. We do not offer clinical trials. Individual results may vary.

  • 43,000+Patients served
  • 4.8Google rating
  • US-licensed503A Pharmacies
Studied for Gut-Lining Inflammation

Studied in lab and animal research for gut-lining inflammation, including IBS and colitis pictures. No completed human trial as a single agent.

Researched for Inflammatory Skin

Researched, mostly in the lab, for inflammatory skin, flares and redness.

Needle-Free Option

An oral option — capsules, nothing to inject.

Part of Your Care Plan

Integrates with broader care as the anti-inflammatory arm of KLOW and Quell.

Clinician Guided

Clinician-guided treatment, prescribed after a provider evaluation.

All treatment plans require medical evaluation and approval. Individual results may vary.

Take control of your health in 6 simple, affordable steps

Personalized Intake

1

Tell us about your health, goals, and history through a secure intake questionnaire.

Clinician Review

2

A licensed clinician reviews your information and determines what's right for you.

Diagnostic Lab Testing

3

Baseline lab work checks your health markers before any peptide is prescribed.

Clinical Evaluation

4

A provider reviews your labs with you in a live video visit and confirms your suitability for peptide therapy.

Medication Delivered

5

Your prescribed medication is prepared by a partner pharmacy and shipped to your home.

Ongoing Support

6

Your progress is monitored with follow-ups and adjustments as needed.

How the program works

Built around 12-week cycles

Peptide programs are sold in 12-week cycles (about 3 months). You can buy one cycle or a bundle of up to 3 cycles up front, with a maximum of 3 cycles per year.

Labs and a provider consultation are required.

Every peptide program starts with lab work and a live consultation with a licensed provider before anything is prescribed.

A year on the programUp to 3 cycles · 52 weeks
  1. Lab panel includedCycle 112 weeksOne cycle at a time
  2. Cycle 212 weeksBundle of 2 · save 7.5%
  3. Cycle 312 weeksBundle of 3 · save 12.5%
  • Clinician consultation & follow-up access
  • All peptide medication for the cycle
  • Shipping to your door
  • Injection supplies & dosing guide

Peptide therapy

Not sure which peptide program is right for you?

Talk it through first in a free 15-minute provider consultation. A U.S.-licensed provider will go over your goals and health history, explain how the programs work, and help you decide whether one is right for you before you commit to a cycle. There is no obligation to start treatment.

Book a Free Provider Consultation

Understanding KPV and inflammation

How a melanocortin fragment quiets an overactive local immune response. Learn how clinician-guided KPV may support gut and skin inflammation without broad immune suppression.

Understanding KPV & Inflammation

Learn about KPV, how it works inside gut and skin cells, and how clinician-guided therapy may fit your care plan.

The Physiology

Proposed Melanocortin Anti-Inflammatory Pathway

α-MSH fragment (KPV) → PepT1 transport → NF-κB blocked → less inflammatory signaling

KPV is the three-amino-acid tail (lysine–proline–valine) of alpha-MSH, one of the body's own anti-inflammatory hormones. It carries the anti-inflammatory activity without the pigmentation effects of the parent molecule.

In laboratory studies, inside gut and skin cells it blocks NF-κB, the switch that drives the inflammatory cascade — a targeted action rather than broad immune suppression. The transporter that carries it into the gut lining, PepT1, becomes more active where the gut is inflamed, which is why researchers expect KPV to concentrate where the problem is.

That mechanism is well described in laboratory work. KPV has not yet been properly studied in people as a single agent, and your provider will say so before you consent.

Symptoms

Symptoms & Signals

KPV is considered when patterns like these are present:

Gut-lining inflammation or IBS-type symptoms
Inflammatory skin, flares and redness
Redness after skin procedures
Aching and fatigue with a "running hot" quality
Feeling generally run-down

Experiencing multiple patterns may warrant clinician evaluation.

Who Is It For?

Who May Benefit from KPV?

KPV may be considered for adults who are:

Dealing with gut-lining inflammation, including IBS and colitis pictures
Managing inflammatory skin — flares, redness, or post-procedure irritation
Looking for a needle-free option (oral capsules)
Already on a repair or immune program where KPV is the anti-inflammatory arm (KLOW, Quell)

Clinical evaluation is required. Your eligibility will be determined by a licensed provider.

Capsules vs Injection

KPV Capsules vs Injectable KPV

Two routes to the same peptide — your provider chooses.

Oral capsules

500 mcg capsules taken daily; nothing to inject.

  • Designed to reach the gut lining (PepT1 transport, lab studies)
  • The needle-free option — the KPV in the Quell program
  • Stored at room temperature

Injectable (KLOW combination vial)

KPV combined with BPC-157, TB-500 and GHK-Cu in one vial.

  • •One injection routine for the KLOW blend; the blend itself has not been studied
  • •Chosen when there is a musculoskeletal or skin-repair component

Route is a provider decision. A patient on both KLOW and Quell takes KPV by two routes — deliberately, never by accident.

Protocol

Protocol Philosophy

KPV is studied as an anti-inflammatory signal, so any response tends to build gradually over a cycle rather than overnight.

An example, not your plan. On this page KPV comes as daily capsules or inside the KLOW combination vial; your provider chooses the route. The 12-week cycle you choose is the program: clinician consultation, peptide medication and free shipping; labs may be required. It is not a dosing schedule; your provider decides your dose, how often and for how long.

Early Phase (Weeks 1–2)

Protocol begins and your baseline is recorded.

Adaptation Phase (Weeks 3–4)

Your body adjusts; no dramatic change is expected yet.

Progression Phase (Weeks 4–6)

Some people report easing symptoms. This is not guaranteed.

Assessment (Weeks 8–12)

Reviewed together against what you described at the start.

Responses vary by individual.

Research Findings and Limits

Research Findings and Limits

What KPV has been studied for, and the kind of study behind each:

Lab and animal studiesGut-lining inflammation
Lab studiesInflammatory skin
Lab studiesTargeted action, not broad immune suppression
Care planCan sit alongside a repair program

Limits of the research. KPV's evidence is mainly laboratory and animal work, with no completed human trial as a single agent. No outcome is guaranteed.

Individual responses vary.

Designed for Safety.Guided by Clinicians.

  • Targeted, not immunosuppressive — in lab studies KPV calms inflammation inside gut and skin cells rather than suppressing the immune system broadly
  • Gradual, not instant — some people report easing around weeks 4–6, though this is not guaranteed, and your provider reviews at 8–12 weeks
  • One peptide, one plan — your provider chooses the route and checks you aren't already taking KPV inside KLOW or Quell

KPV is excluded in pregnancy and breastfeeding, and your full medication list and any other programs are reviewed before it is prescribed

KPV vial standing on a stone plinth

Serving all 50 States with science-first,
outcome-driven wellness.

Compounded peptides ship from licensed US pharmacies. Certain products and delivery forms may vary by state — our team will help you find the best option for your needs.

Our patients trust us because we combine real medicine with real care.

4.8 average rating

Frequently Asked Questions

Get answers to commonly asked questions.

Yes. KPV requires evaluation by a licensed provider, who determines eligibility and the route — capsules or the KLOW combination vial — before anything is prescribed.

KPV is a three-amino-acid peptide (lysine–proline–valine), the active anti-inflammatory tail of alpha-MSH, one of the body's own anti-inflammatory hormones. It carries the anti-inflammatory activity without the pigmentation effects of the parent molecule and is studied for gut and skin inflammation.

No. KPV is compounded by a licensed 503A pharmacy and is not FDA-approved as a finished drug. Its evidence is mainly laboratory and animal work, with no completed human trial as a single agent.

In laboratory studies, KPV is carried into cells by the PepT1 transporter and blocks NF-κB, the switch that drives the inflammatory cascade. Because PepT1 is more active in inflamed gut lining, researchers expect KPV to concentrate where the inflammation is — a targeted action rather than broad immune suppression. It has not been properly studied in people as a single agent.

Your provider decides. Capsules (500 mcg to 1 mg daily) are designed to reach the gut lining directly and are the needle-free option; the injectable form comes inside the KLOW combination vial with BPC-157, TB-500 and GHK-Cu, chosen when skin or musculoskeletal repair is part of the plan.

Still have questions? Contact us